2008 |
R21 |
CA132039 |
RFA-CA-07-035 |
NELSON, EDWARD L |
UNIVERSITY OF CALIFORNIA-IRVINE |
APPLICATION OF A NOVEL NANOTECHNOLOGY FOR MOLECULAR PROFILING OF TUMOR CELLULAR E |
Complete |
2011 |
R21 |
CA155479 |
RFA-CA-10-005 |
MCDONALD, JOHN F |
GEORGIA INSTITUTE OF TECHNOLOGY |
USE OF NANOGELS TO TARGET DELIVERY OF SIRNA TO CANCER CELLS IN MICE |
Complete |
2015 |
R21 |
CA196426 |
RFA-CA-14-003 |
VO-DINH, TUAN |
DUKE UNIVERSITY |
NANOPLASMONICS-BASED MOLECULAR ANALYSIS TOOL FOR MOLECULAR BIOMARKERS OF CANCER |
Complete |
2010 |
R21 |
CA147975 |
RFA-CA-09-008 |
SZMACINSKI, HENRYK |
UNIVERSITY OF MARYLAND BALTIMORE |
METHOD FOR DETECTION OF SECRETED PROTEINS IN SINGLE CELL ASSAYS |
Complete |
2007 |
R21 |
CA120566 |
RFA-CA-07-001 |
HUANG, FAQING |
UNIVERSITY OF SOUTHERN MISSISSIPPI |
FOLATE RECEPTOR-MEDIATED SIRNA DELIVERY TO CANCER CELLS |
Complete |
2009 |
R21 |
CA134359 |
RFA-CA-08-009 |
FOWLER, CAROL B |
AMERICAN REGISTRY OF PATHOLOGY, INC. |
RECOVERY OF PROTEINS FROM FORMALIN-FIXED TISSUES UNDER HIGH HYDROSTATIC PRESSURE |
Complete |
2020 |
R21 |
CA240220 |
RFA-CA-19-019 |
ALEXANDRAKIS, GEORGIOS |
UNIVERSITY OF TEXAS ARLINGTON |
Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy |
Active |
2006 |
R21 |
CA120732 |
RFA-CA-06-003 |
MEYER, TOBIAS |
STANFORD UNIVERSITY |
DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS |
Complete |
2009 |
R21 |
CA138295 |
RFA-CA-08-006 |
LESSNICK, STEPHEN L. |
UNIVERSITY OF UTAH |
ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER |
Complete |
2012 |
R21 |
CA173205 |
RFA-CA-12-002 |
TAO, NONGJIAN |
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS |
CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES |
Complete |
2016 |
R21 |
CA204706 |
RFA-CA-15-002 |
BURGETT, ANTHONY WG |
UNIVERSITY OF OKLAHOMA NORMAN |
MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS |
Complete |
2019 |
R21 |
CA240580 |
RFA-CA-18-002 |
MONTAGNA, CRISTINA |
ALBERT EINSTEIN COLLEGE OF MEDICINE |
Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions |
Active |
2000 |
R21 |
CA086132 |
PAR-99-100 |
MAJUMDAR, ARUNAVA |
UNIVERSITY OF CALIFORNIA BERKELEY |
OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER |
Complete |
2002 |
R21 |
CA094393 |
PAR-99-102 |
CHODOSH, LEWIS A |
UNIVERSITY OF PENNSYLVANIA |
TEMPORAL ANALYSIS OF MAMMARY CARCINOGENESIS |
Complete |
2005 |
R21 |
CA116365 |
RFA-CA-05-003 |
GREEN, ROLAND D |
NIMBLEGEN SYSTEMS, INC. |
MAPPING REGULATORY PATHWAYS IN CANCERS |
Complete |
2008 |
R21 |
CA126635 |
RFA-CA-07-035 |
KEELY, PATRICIA J |
UNIVERSITY OF WISCONSIN-MADISON |
USING NEW OPTICAL TECHNIQUES TO STUDY CELL SIGNALING IN 3D MATRICES |
Complete |
2011 |
R21 |
CA157417 |
RFA-CA-10-005 |
ZEICHNER, STEVEN L |
CHILDREN'S RESEARCH INSTITUTE |
DEVELOPMENT OF AN IN VIVO SCREENING TECHNOLOGY FOR CANCER VACCINE IMMUNOGENS |
Complete |
2015 |
R21 |
CA191133 |
RFA-CA-14-005 |
MITRAGOTRI, SAMIR S |
UNIVERSITY OF CALIFORNIA SANTA BARBARA |
ASSESSING THE RISK OF UV-INDUCED SKIN CANCER VIA NON-INVASIVE EPIDERMAL SAMPLING |
Complete |
2010 |
R21 |
CA137703 |
RFA-CA-09-008 |
LIU, GUODONG |
NORTH DAKOTA STATE UNIVERSITY |
DEVELOPMENT OF A HAND-HELD CANCER BIOMARKER MONITOR |
Complete |
2007 |
R21 |
CA126700 |
RFA-CA-07-001 |
DING, ZHIYONG |
UT MD ANDERSON CANCER CTR |
EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH |
Complete |
2019 |
R33 |
CA225458 |
RFA-CA-18-003 |
KETTENBACH, ARMINJA NADINE |
DARTMOUTH COLLEGE |
Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics |
Active |
2018 |
R33 |
CA225863 |
RFA-CA-17-011 |
LU, JUN |
YALE UNIVERSITY |
CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer |
NCE |
2007 |
R33 |
CA120726 |
RFA-CA-07-002 |
MOORE, PATRICK S. |
UNIVERSITY OF PITTSBURGH AT PITTSBURGH |
EMERGING TECHNOLOGIES APPLIED TO THE DISCOVERY OF HUMAN TUMOR VIRUSES |
Complete |
2014 |
R33 |
CA177333 |
RFA-CA-13-002 |
FEDERSPIEL, MARK J |
MAYO CLINIC ROCHESTER |
VALIDATING TECHNOLOGY TO OPTIMIZE ANTIBODY AFFINITY FOR TARGETING THERAPEUTICS |
Complete |
2017 |
R33 |
CA212697 |
RFA-CA-16-002 |
KLEIN, ALLON MOSHE |
HARVARD MEDICAL SCHOOL |
Droplet microfluidic technology for single cell cancer genomics |
Complete |
2001 |
R33 |
CA084691 |
PAR-98-067 |
MELDRUM, DEIRDRE R. |
UNIVERSITY OF WASHINGTON |
AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION |
Complete |
2009 |
R33 |
CA134304 |
RFA-CA-08-008 |
SHI, HUIDONG |
GEORGIA REGENTS UNIVERSITY |
APPLICATION OF 454 SEQUENCING TO CANCER EPIGENOMICS |
Complete |
2013 |
R33 |
CA177462 |
RFA-CA-12-003 |
BAILEY, RYAN C |
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN |
MESO-PLEX MIRNA AND PROTEIN PROFILING FOR CANCER DIAGNOSTICS USING CHIP-INTEGRATE |
Complete |
2020 |
R33 |
CA240181 |
RFA-CA-19-020 |
COOKS, ROBERT GRAHAM |
PURDUE UNIVERSITY |
Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies |
Active |
2019 |
R33 |
CA225498 |
RFA-CA-18-003 |
CHEN, SIDI |
YALE UNIVERSITY |
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers |
Active |
2002 |
R33 |
CA096309 |
PAR-01-104 |
LI, HONGHUA |
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH |
A GENETIC APPROACH TO GENOME-SCALE ANALYSIS OF CANCERS |
Complete |
2018 |
R33 |
CA222344 |
RFA-CA-17-011 |
SALIPANTE, STEPHEN J |
UNIVERSITY OF WASHINGTON |
Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods |
NCE |
2007 |
R33 |
CA122900 |
RFA-CA-07-002 |
DOVICHI, NORMAN J |
UNIVERSITY OF WASHINGTON |
CHEMICAL CYTOMETRY FOR NEOPLASIA PROGNOSIS-BARRETT'S ESOPHAGUS |
Complete |
2014 |
R33 |
CA177449 |
RFA-CA-13-002 |
BLAIR, SARAH L |
UNIVERSITY OF CALIFORNIA SAN DIEGO |
NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER |
Complete |
2017 |
R33 |
CA212806 |
RFA-CA-16-004 |
ZILBERBERG, JENNY |
HACKENSACK UNIVERSITY MEDICAL CENTER |
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells |
NCE |
2001 |
R33 |
CA084740 |
PAR-98-067 |
ENGELWARD, BEVIN P. |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
FLUORESCENCE DETECTION OF GENETIC INSTABILITY IN MICE |
Complete |
2009 |
R33 |
CA140039 |
RFA-CA-08-008 |
ELLEDGE, STEPHEN J |
BRIGHAM AND WOMEN'S HOSPITAL |
A MULTIPLEX GENOME-WIDE SHRNA SCREENING PLATFORM FOR CANCER-LETHAL GENE DISCOVERY |
Complete |
2013 |
R33 |
CA177456 |
RFA-CA-12-003 |
DI CARLO, DINO |
UNIVERSITY OF CALIFORNIA LOS ANGELES |
ISOLATING CIRCULATING TUMOR CELLS USING A CENTRIFUGE ON A CHIP |
Complete |
2019 |
R33 |
CA225549 |
RFA-CA-18-003 |
TAVANA, HOSSEIN |
UNIVERSITY OF AKRON |
A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery |
Active |
2002 |
R33 |
CA095957 |
PAR-01-104 |
BEACHY, PHILIP A |
JOHNS HOPKINS UNIVERSITY |
GENOME-BASED TARGETING OF THE HEDGEHOG PATHWAY IN CANCER |
Complete |
2018 |
R33 |
CA228979 |
RFA-CA-17-011 |
SCHRUM, ADAM G |
UNIVERSITY OF MISSOURI-COLUMBIA |
Multiplex matrix ELISA for T cell protein-interaction networks in cancer |
Active |
2007 |
R33 |
CA128726 |
RFA-CA-07-016 |
MACBEATH, GAVIN |
HARVARD UNIVERSITY |
QUANTITATIVE INTERACTION NETWORKS FOR TYROSINE-PHOSPHORYLATED PROTEINS |
Complete |
2014 |
R33 |
CA181771 |
RFA-CA-13-002 |
LOEB, LAWRENCE A |
UNIVERSITY OF WASHINGTON |
VALIDATION AND ADVANCED DEVELOPMENT OF DUPLEX SEQUENCING |
Complete |
2017 |
R33 |
CA212968 |
RFA-CA-16-002 |
SINGH, ANKUR |
CORNELL UNIVERSITY |
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics |
Complete |
2001 |
R33 |
CA083234 |
PAR-98-067 |
MAKRIGIORGOS, G. MIKE |
DANA-FARBER CANCER INSTITUTE |
TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER |
Complete |
2013 |
R33 |
CA173300 |
RFA-CA-12-003 |
PAULOVICH, AMANDA G |
FRED HUTCHINSON CANCER RESEARCH CENTER |
ADVANCED DEVELOPMENT OF IMMUNO-MRM TECHNOLOGY TO ANALYZE ARCHIVED CANCER TISSUES |
Complete |
2013 |
R33 |
CA173264 |
RFA-CA-12-003 |
TACKETT, ALAN JACKSON |
UNIV OF ARKANSAS FOR MED SCIS |
DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION |
Complete |
2016 |
R33 |
CA196445 |
RFA-CA-15-003 |
LAM, KIT S |
UNIVERSITY OF CALIFORNIA AT DAVIS |
GESI: a novel technology for functional imaging in living cells |
Complete |
2012 |
R33 |
CA173382 |
RFA-CA-12-003 |
ZU, YOULI |
METHODIST HOSPITAL RESEARCH INSTITUTE |
ACTIVATABLE ONE-DROP AND ONE-STEP ASSAY FOR CIRCULATING TUMOR CE |
Complete |
2019 |
R33 |
CA229042 |
RFA-CA-18-003 |
SCHNECK, JONATHAN P |
JOHNS HOPKINS UNIVERSITY |
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells |
Active |